Energy balance
Weight loss interventions, particularly pharmacologic treatments like GLP-1 receptor agonists (e.g., semaglutide, tirzepatide), significantly reduce OSA severity and may reduce cardiovascular disease risk.
If you have sleep apnea and are overweight, losing weight is one of the most powerful things you can do for your heart and your sleep. Modern medications like semaglutide or tirzepatide can help you lose significant weight, which directly reduces the severity of your sleep apnea and your risk of heart disease. Discuss these options with your doctor.
a 10% or more weight loss from baseline can result in a 21% or more reduction in CVD
Why this rating
Supported by large RCTs (SELECT, SURMOUNT-OSA) and meta-analyses showing robust weight loss and CV benefit.
Source
Beyond continuous positive airway pressure for cardiovascular risk reduction in patients with obstructive sleep apnea
William Healy et al. · SLEEP Advances · 2024
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →